Mandate

Vinge has advised D. Carnegie & Co in connection with a directed issue of approximately 6.5 million Class B shares

April 19, 2016

Vinge has advised D. Carnegie & Co AB (publ) (”D. Carnegie”), listed on Nasdaq Stockholm, in connection with the company’s directed cash share issue of 6,539,900 Class B shares at a subscription price of SEK 72.50 per share, raising proceeds of approximately SEK 474,000,000 before transaction costs. The subscription price was determined through an accelerated book-building process. Subscribers in the share issue were approximately 60 Swedish and international institutional investors.

Vinge’s team consisted of Jesper Schönbeck, Sofie Bjärtun and André Isacson.  

Related

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025

Vinge advises OsteoCentric on the public offer for Integrum

OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a subsidiary of OsteoCentric Technologies, Inc., has made a public offer for all shares in Integrum AB (publ). The offer values all shares in Integrum at approximately SEK 939 million.
July 23, 2025